Coronavirus disease 2019: The harms of exaggerated information and non‐evidence‐based measures

The evolving coronavirus disease 2019 (COVID-19) epidemic1 is certainly cause for concern. Proper communication and optimal decision-making is an ongoing challenge, as data evolve. The challenge is compounded, however, by exaggerated information. This can lead to inappropriate actions. It is important to differentiate promptly the true epidemic from an epidemic of false claims and potentially harmful actions.

[1]  D. Krewski,et al.  Effectiveness of personal protective measures in reducing pandemic influenza transmission: A systematic review and meta-analysis. , 2017, Epidemics.

[2]  J. Robins,et al.  Transmissibility of 1918 pandemic influenza , 2004, Nature.

[3]  Bill Gates,et al.  Responding to Covid-19 - A Once-in-a-Century Pandemic? , 2020, The New England journal of medicine.

[4]  Jianhong Wu,et al.  An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov) , 2020, Infectious Disease Modelling.

[5]  M. Drebot,et al.  An Outbreak of Human Coronavirus OC43 Infection and Serological Cross-reactivity with SARS Coronavirus. , 2006, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[6]  K. Kupferschmidt.  Study claiming new coronavirus can be transmitted by people without symptoms was flawed , 2020 .

[7]  E. Walsh,et al.  Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations , 2013, The Journal of infectious diseases.

[8]  Tom Jefferson,et al.  Physical interventions to interrupt or reduce the spread of respiratory viruses: systematic review , 2008, BMJ : British Medical Journal.

[9]  Cecile Viboud,et al.  Global mortality associated with seasonal influenza epidemics: New burden estimates and predictors from the GLaMOR Project , 2019, Journal of global health.

[10]  M. Lipsitch,et al.  Public health interventions and epidemic intensity during the 1918 influenza pandemic , 2007, Proceedings of the National Academy of Sciences.

[11]  W. Yin,et al.  [Early containment strategies and core measures for prevention and control of novel coronavirus pneumonia in China]. , 2020, Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine].

[12]  J. Gomes,et al.  Uncanny similarity of unique inserts in the 2019-nCoV spike protein to HIV-1 gp120 and Gag , 2020, bioRxiv.

[13]  Zunyou Wu,et al.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. , 2020, JAMA.